A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Treprostinil Palmitil Inhalation Powder
Related studies linked through entity extraction aliases.
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3